Bank Pictet & Cie (Asia)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CM
Bank Pictet & Cie (Asia)'s IBB Position: Q2 2017 in Review
Bank Pictet & Cie (Asia) sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 10,203 shares — an estimated $997K sold.
Bank Pictet & Cie (Asia) first reported a position in IBB in Q4 2015 and held it in 6 quarters. The position peaked at $1.59M in Q4 2015. 562 funds tracked by Wall St. Rank hold IBB as of Q2 2017.
- Bank Pictet & Cie (Asia) reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
- Bank Pictet & Cie (Asia) sold 10,203 iShares Biotechnology ETF shares in Q2 2017, an estimated $997K.
- Bank Pictet & Cie (Asia) first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 6 quarters.
- Bank Pictet & Cie (Asia)'s iShares Biotechnology ETF position peaked at $1.59M in Q4 2015.
- 562 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.
Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2017, filed 9 Aug 2017.